Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New estrogen agonists and antagonists

Sep. 13, 1996

Novel treatment for bone loss

Sep. 13, 1996

Meiji Seika discloses natural progesterone antagonists

Sep. 6, 1996

U.S. approval for Serono infertility product

Sep. 6, 1996

Moxisylyte to treat erectile dysfunction

Sep. 6, 1996

Safe and effective treatment of erectile dysfunction with sildenafil

Sep. 6, 1996

Joint venture to develop treatment for male impotence

Sep. 6, 1996

Bio-Technology General to seek approval for sublingual testosterone

Sep. 6, 1996

AGE-specific monoclonal antibody from Alteon

Sep. 6, 1996

Novo Nordisk licenses Scios' insulinotropin

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.